Tavapadon eases motor symptoms in early Parkinson’s: Study
WEB3 days ago — TEMPO-1 study tested efficacy, safety, tolerability as single therapy. by Andrea Lobo September 30, 2024. Treatment with tavapadon as a fixed-dose single therapy significantly improved motor function in early stage Parkinson’s disease, according to top-line data from a completed Phase 3 trial.
New Parkinson’s drug could slow or reverse progression of …
WEBAug 21, 2024 — New Parkinson’s drug could slow or reverse progression of disease, researchers say: ‘Big step forward’. Published On. August 21, 2024. Social Media. Share this article.
A Potential Parkinson’s Treatment Has Promising Results
WEBJun 20, 2024 — A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment...
Parkinson's News Today Home | Parkinson's News Today
WEBParkin protein tied to Parkinson’s disease aids anti-tumor responses. Parkin, a protein linked to Parkinson’s disease that’s lost in certain types of cancer, triggers the release of signaling molecules that activate and attract immune cells to fight tumors, according to a study led by researchers at The Wistar Institute in Philadelphia.
Parkinson's News -- ScienceDaily
WEB3 days ago — Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
New Parkinson’s Treatments in the Clinical Trial Pipeline for 2024
WEBSep 26, 2023 — Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
Parkinson's disease - Latest research and news - Nature
WEB5 days ago — Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
Parkinson's vaccine seen to target toxic protein in Phase 1 trial
WEBMar 11, 2024 — Treatment with UB-312, a vaccine designed to trigger an immune response against toxic clumps of the alpha-synuclein protein, reduced these damaging aggregations in people with Parkinson’s disease in a Phase 1 trial.
Top 10 Parkinson’s Disease Stories of 2021
WEBParkinson’s News Today The top 10 most-read Parkinson’s news stories of 2021 on Parkinson’s News Today include exercise recommendations from the Parkinson’s Foundation and the American College of Sports Medicine.
Breakthrough Parkinson’s Treatment Enters Human Trials
WEBAug 7, 2024 — A clinical trial has begun to offer a new treatment to people with Parkinson’s disease, following a study by University of Wisconsin–Madison scientists. This study, conducted on non-human primates, confirmed that the therapeutic delivery method is …